← brief for 2026-10-21 · Slowing decline

SGLT2 INHIBITORS IN CHRONIC KIDNEY DISEASE WITH AND WITHOUT DIABETES: RENAL AND CARDIOVASCULAR OUTCOMES – A LITERATURE REVIEW

Article No results yet Not peer reviewed

Key takeaways

This review summarizes major trials on a class of drugs called SGLT2 inhibitors. It looks at how these drugs protect the kidneys and heart. It is a summary of existing research, not a new study with its own results.

Who did this work

João Batista Rebouças Lima · Vanilson Pires Cerqueira Jr · Vanessa Figueredo de Brito · Julia Ceolin Leonardi · Mikael Coutinho Silva

Source

Article · OpenAlex, CKD works · 2026-10-20
https://doi.org/10.5281/zenodo.23511540